Surgery for Testicular Cancer: UK and European Experience
Surgery for metastatic testis cancer is done for several reasons. It gives diagnostic information, especially in staging apparent stage 1 disease, it provides prognostic information by defining the pathological results of chemotherapy, and, most importantly, is done therapeutically, to remove residual viable disease. The purpose of this article is to define European practice, for comparison with that in the USA, as described elsewhere by Foster and colleagues. The author will, of necessity, provide the most detailed information on UK, rather than general European, practice, using data, involving 909 patients (Table 34.1), from a survey carried out of the majority of British centres performing surgery for metastatic testis cancer .
KeywordsEurope Adenocarcinoma Sarcoma Expense Teratoma
Unable to display preview. Download preview PDF.
- 1.Kirk D, Fordham MVP, Wallace DM et al. Surgery for metastatic germ cell tumours: a survey of practice in Britain. UroOncology 2001;1:123–129Google Scholar
- 4.Donohue JP. Editorial comment on “Distribution of peritoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumours.” J Urol 1992;148;1815–1817Google Scholar
- 5.Fossa S, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE. Is post-chemotherapy retroperintoneal surgery necessary in patients with non-seminomatous testicular cancer and minimal residual tumour masses. J Clin Oncol 1990;10;569–573Google Scholar